Markets: 2026-08-19 Close
The major indexes, sector leaders and laggards, and 8 verified stock movers from the 2026-08-19 session.
Published 2026-08-20 · Session 2026-08-19 · AI-assisted research and writing
A sourced recap of the previous completed U.S. trading session. Closing moves are not real-time quotes.
The market tape
- **S&P 500 (SPX)**: +0.21%, closed at 7,707.98 - **Nasdaq Composite (COMP)**: +0.16%, closed at 26,331.09 - **Dow Jones Industrial Average (DJIA)**: +0.22%, closed at 53,463.05 - **Russell 2000 (RUT)**: +0.50%, closed at 3,032.94
Sector leaders and laggards
- Leaders: Health Care +3.51%; Materials +1.43% - Laggards: Information Technology -1.07%
Notable movers
Moderna, Inc. (MRNA) +176.97%
Moderna and Merck reported that their personalized mRNA cancer therapy combined with Keytruda met the primary endpoint in a Phase 3 melanoma trial. An exceptionally large, high-volume move in a large-cap biotechnology company, with implications for cancer vaccines, mRNA platforms and biotech financing.
Sources: dated closing quote · catalyst reporting
Merck & Co., Inc. (MRK) +12.60%
Merck co-developed the personalized mRNA melanoma therapy with Moderna and participated directly in the positive Phase 3 readout. A rare double-digit move in a megacap pharmaceutical company that materially changes expectations for Keytruda's lifecycle and personalized oncology.
Sources: dated closing quote · catalyst reporting
Marvell Technology, Inc. (MRVL) +9.85%
Marvell disclosed an expanded custom-silicon relationship with Google spanning AI accelerators, networking and memory products. The move highlights hyperscaler demand for custom AI silicon and the competitive positioning of merchant-chip suppliers against general-purpose GPU vendors.
Sources: dated closing quote · primary catalyst source · catalyst corroboration
Target Corporation (TGT) +4.28%
Target reported improving results under its new CEO and raised its expectations for fiscal 2026. A prominent turnaround signal from a major discretionary retailer, with implications for consumer spending, inventories and promotional intensity.
Sources: dated closing quote · catalyst reporting
The Estée Lauder Companies Inc. (EL) +16.39%
Estée Lauder's fiscal fourth-quarter profit report was received positively and was cited as one of the company reports supporting the broader market. A double-digit revaluation of a global beauty company and a notable signal for premium consumption, travel retail and China-sensitive demand.
Sources: dated closing quote · catalyst corroboration
The TJX Companies, Inc. (TJX) -4.20%
TJX released quarterly results, and the shares finished lower in a sell-the-news reaction during a session featuring several major retail reports. The weakness contrasted with gains in Target and Lowe's, providing a differentiated read on off-price retail expectations and valuation.
Sources: dated closing quote · primary catalyst source
Lowe's Companies, Inc. (LOW) +2.36%
Lowe's quarterly earnings release was the principal company-specific event, and shares closed higher as investors assessed home-improvement demand and the professional-contractor business. The result offered a high-value read-through on housing turnover, large-project deferrals and consumer spending on home improvement.
Sources: dated closing quote · primary catalyst source
Analog Devices, Inc. (ADI) -0.85%
Analog Devices released fiscal third-quarter results, but shares finished modestly lower amid broader semiconductor weakness. Although the percentage move was modest, the high-dollar-volume response provided a useful read on analog-chip demand during a volatile semiconductor session.
Sources: dated closing quote · primary catalyst source
Stock spotlight
Today’s detailed follow-up focuses on **Moderna, Inc. (MRNA)**, the strongest verified editorial candidate from this slate.
_MacroShed Markets is informational analysis, not investment advice._
Sources
- Moderna Stock Price History
- Moderna short-sellers stare at record one-day loss as shares surge on vaccine data
- Merck & Co. Stock Price History
- Moderna, Merck breakthrough could usher in wave of cancer vaccines
- MRVL Historical Prices
- Marvell Technology SEC filings
- Treasury Buyback Lifts US Stocks as Moderna Cancer Data Sparks Rally
- Target Stock Price History
- Target regains its footing under a new CEO and raises expectations for 2026
- The Estée Lauder Companies Stock Price History
- How major US stock indexes fared Wednesday 8/19/2026
- The TJX Companies Stock Price History
- TJX News Releases
- Lowe's Companies Stock Price History
- Lowe's Press Releases
- Analog Devices Stock Price History
- Analog Devices News Releases
- Maravai LifeSciences Holdings Stock Price History
- Steel Dynamics Stock Price History
- XLB Historical Stock Price Data
- Palantir Technologies Stock Price History
- XLK Historical Stock Price Data